TrialReader


Evaluation of EMI in Patients With Micra Leadless Pacemaker

NCT03508128 — Completed, 7 participants, Edward-Elmhurst Health System

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Evaluation of Surgical Electromagnetic Interference in Medtronic Micra Leadless Pacemaker

RegistryNCT03508128
StatusCompleted
Study typeObservational
Enrollment7 (Actual)
SponsorEdward-Elmhurst Health System (Other)
ConditionsElectromagnetic Interference
Interventionssurgical procedure (Other)
Datesstart 2018-04-04, primary completion 2018-08-18, completion 2018-08-18, first posted 2018-04-25, last updated 2018-08-21
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Electromagnetic Interference All trials of surgical procedure

-Summary

Subjects with Medtronic Micra leadless pacemaker who require surgical procedures will have postoperative interrogations reviewed for evidence of electromagnetic interference (EMI).

Expand all sections  ·  Collapse all

+Detailed description

Patients with pacemakers have a potential risk of EMI from sources including electrosurgery which can cause oversensing, pacing inhibition and device reset. There is limited data on surgical EMI in Medtronic Micra leadless pacemakers. The goal of this study is to evaluate for surgical EMI in subjects with leadless pacemakers.

Subjects with Micra leadless pacemakers requiring surgery will have procedure records reviewed for type of procedure and use of electrosurgery. Next postoperative device interrogation will be reviewed for evidence of EMI. EMI will be evaluated by review of sensing integrity counter, heart rate histograms and device reset.

+Arms and interventions

ArmTypeInterventionsDescription
Micra subjectsOther: surgical procedureSurgical procedure
  • surgical procedure (Other): Surgical procedure

+Outcome measures

Primary outcomes

  • EMI [up to 6 months next postop interrogation]: Number of subjects with evidence of EMI determined by sensing integrity counter and heart rate histograms

Secondary outcomes

  • Device reset [up to 6 months next postop interrogation]: Number of subjects with change in programmed parameters showing device reset VVI 65 5V@.4ms

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion criteria:

* subjects with an implanted Micra pacemaker who required a surgical procedure

Exclusion Criteria:

* no Micra pacemaker

+Locations (1)

FacilityCityCountryStatus
EdwardElmhurst HealthcareNaperville, IllinoisUnited States

+Investigators

My Notes